Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy

scientific article

Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1018017426
P356DOI10.1186/1741-7015-11-45
P932PMC publication ID3621796
P698PubMed publication ID23438147
P5875ResearchGate publication ID235727861

P50authorRamon Sagarra ÁlamoQ59204213
Joan J CabréQ59204242
Jordi Salas-SalvadóQ35028955
Bernardo CostaQ57298267
P2093author name stringJosep L Piñol
Oriol Solà-Morales
Xavier Mundet
Francisco Barrio
Ramon Sagarra
DE-PLAN-CAT/PREDICE Research Group
P2860cites workInternational Diabetes Federation: a consensus on Type 2 diabetes preventionQ80241108
Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reportingQ21245257
Genetic prediction of future type 2 diabetesQ21563435
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adultsQ22250879
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminQ22250892
Diagnosis and Classification of Diabetes MellitusQ22255454
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetesQ24642456
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceQ28186874
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysisQ30829257
A1C level and future risk of diabetes: a systematic reviewQ33932887
Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention deliveryQ34371263
Risk assessment tools for identifying individuals at risk of developing type 2 diabetesQ35095114
Risk models and scores for type 2 diabetes: systematic reviewQ35575823
A risk score to predict type 2 diabetes mellitus in an elderly Spanish Mediterranean population at high cardiovascular riskQ35839851
Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal communityQ37122916
Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling studyQ37271291
Tools for predicting the risk of type 2 diabetes in daily practiceQ37330190
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in EuropeQ39928512
A European evidence-based guideline for the prevention of type 2 diabetes.Q43100057
A1C: recommendations, debates, and questions.Q43235338
Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle interventionQ44233266
The diabetes risk score: a practical tool to predict type 2 diabetes riskQ44333486
Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: one-year follow-up of the FIN-D2D projectQ44558382
Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population.Q51376301
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.Q51384908
The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) ProjectQ58417532
P407language of work or nameEnglishQ1860
P921main subjectFinlandQ33
P304page(s)45
P577publication date2013-02-21
P1433published inBMC MedicineQ4835947
P1476titleShifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy
P478volume11

Reverse relations

cites work (P2860)
Q34671155Diabetes mellitus: The epidemic of the century
Q36306607Different type 2 diabetes risk assessments predict dissimilar numbers at 'high risk': a retrospective analysis of diabetes risk-assessment tools
Q35088520Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population
Q34159256Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.
Q51458635Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower threshold to identify 'high risk' is required.
Q37693898Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
Q37115361Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study
Q34798255Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population
Q36842120Rationale and design of the DP-TRANSFERS project: diabetes prevention-transferring findings from European research to society in Catalonia
Q54702903Uptake of screening for type 2 diabetes risk in general dental practice; an exploratory study.
Q35906741Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol
Q58778969Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population
Q37322783Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
Q51307056[Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society].
Q88983094Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018

Search more.